Press Releases

Tigermed to present at the 41st Annual J.P. Morgan Healthcare Conference

Dec 27, 2022

Tigermed (300347.SZ/3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, will be present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 8:00am Pacific Time.
 
Tigermed presentation will be part of the APAC & LatAm and Not-for-Profit Tracks and will be taken place at JW Marriott San Francisco Union Square (515 Mason Street, SFO, CA)

A live webcast (audio) of the presentation can be accessed at:

https://jpmorgan.metameetings.net/events/healthcare23/sessions/44012-tigermed/webcast?gpu_only=true&kiosk=true
 
The webcast replay will be available afterwards via company's website under the Investors section.

 

About Tigermed

Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are committed to moving our customers through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 100 subsidiaries and 170 offices and sites, with over 10,000 employees across 53 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibility for healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.

 

For more information:

Investor: ir@tigermedgrp.com

Media: pr@tigermedgrp.com